Bullish option flow detected in Bristol Myers Squibb with 17,929 calls trading, 1.8x expected, and implied vol increasing over 1 point to 28.63%. Sep-24 46 calls and Jan-25 35 puts are the most active options, with total volume in those strikes near 12,800 contracts. The Put/Call Ratio is 0.42. Earnings are expected on July 26th.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BMY:
- Bristol Myers announces FDA accelerated approval of Krazati for CRC
- FDA approves Mirati’s Krazati sNDA for colorectal cancer
- Bristol Myers: EMA validates extension application for subcutaneous nivolumab
- Bristol Myers says FDA grants accelerated approval of Augtyro
- I-Mab announces clinical trial collaboration with Bristol Myers